China Pharma Holdings (CPHI) EBT Margin (2010 - 2026)
China Pharma Holdings (CPHI) reported EBT Margin of 116.23% for Q1 2026, down 4709.0% on a YoY basis from 2.52% in Q1 2025, and down 16.6% quarter-over-quarter from 99.68% in Q4 2025.
China Pharma Holdings (CPHI) EBT Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported EBT Margin for 17 years, with the latest figure at 116.23% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 4709.0% year-over-year to 116.23%; the trailing twelve-month figure through Mar 2026 stood at 88.82% (up 1748.0% YoY), and the FY2025 full-year result was 76.91%, up 2767.0% from the prior year.
- EBT Margin for Q1 2026 stood at 116.23%, down from 99.68% in the prior quarter.
- The five-year high for EBT Margin was 24.28% in Q1 2023, with the low at 155.48% in Q2 2024.
- Historically, EBT Margin has averaged 72.89% across 5 years, with a median of 64.18% in 2022.
- Annual changes were most pronounced in 2024 — EBT Margin sank 10147 bps — and 2025, when it soared 10397 bps.
- China Pharma Holdings' EBT Margin stood at 43.28% in 2022, then tumbled by 32 bps to 57.32% in 2023, then sank by 88 bps to 107.98% in 2024, then gained by 8 bps to 99.68% in 2025, then decreased by 17 bps to 116.23% in 2026.
- The last three EBT Margin figures came in at 116.23% (Q1 2026), 99.68% (Q4 2025), and 86.15% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | -116.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.23% |
| Dec 31, 2025 | -99.68% |
| Sep 30, 2025 | -86.15% |
| Jun 30, 2025 | -51.51% |
| Mar 31, 2025 | -69.13% |
| Dec 31, 2024 | -107.98% |
| Sep 30, 2024 | -101.61% |
| Jun 30, 2024 | -155.48% |
| Mar 31, 2024 | -69.78% |
| Dec 31, 2023 | -57.32% |
| Sep 30, 2023 | -43.12% |
| Jun 30, 2023 | -54.02% |
| Mar 31, 2023 | -24.28% |
| Dec 31, 2022 | -43.28% |
| Sep 30, 2022 | -40.22% |
| Jun 30, 2022 | -55.07% |
| Mar 31, 2022 | -64.18% |
| Dec 31, 2021 | -33.94% |
| Sep 30, 2021 | -41.78% |
| Jun 30, 2021 | -34.14% |